Successful Erlotinib Treatment for a Patient with Gefitinib-Related Hepatotoxicity and Lung Adenocarcinoma Refractory to Intermittently Administered Gefitinib

A 73-year-old Japanese man was histologically diagnosed with lung adenocarcinoma harboring an exon 19 deletion in the epidermal growth factor receptor. The patient was treated with gefitinib for 6 weeks until he developed substantially elevated hepatic enzyme levels that resulted in the discontinuat...

全面介紹

書目詳細資料

Principais autores:	Tatsuya Nagano, Yoshikazu Kotani, Kazuyuki Kobayashi, Masahiro Katsurada, Yukihisa Hatakeyama, Suya Hori, Daisuke Tamura, Daisuke Kasai, Yasuhiro Funada, Yoshihiro Nishimura
格式:	Artigo
語言:	Inglês
出版:	Wiley 2011-01-01
叢編:	Case Reports in Pulmonology
在線閱讀:	http://dx.doi.org/10.1155/2011/812972
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!